Way back in a January 2007 post, I pointed out the growth opportunity for
According to the article, Cardinal is rapidly growing its Chinese drug distribution business, while expanding manufacturing in
Just consider what’s been going on in
- Swiss-based Zuellig Pharma has long been a major player in
Asiaand established a Chinese presence before distribution industry was open to direct foreign investment.
- Global wholesaler Alliance Boots entered in January 2007 by buying a 50 percent stake in Guangzhou Pharmaceuticals Corp., the third-largest pharmaceutical wholesaler in
- US-based BMP Sunstone (BJGP) has been actively acquiring Chinese drug wholesalers. (BMP is also linked to Alliance Boots via the
The era of global wholesalers is coming, with or without a U.S. importation law. Perhaps it's time to start considering how it will alter manufacturer-wholesaler relationships.
And to those readers for whom it is relevant: L'Shanah Tovah!